Clincosm LogoSign in Get a demo

Evaluation of the Intravenous Tissue Plasminogen Activator Treatment Algorithm of Nursing Intern Students

Sponsor
Dokuz Eylul University (Other)
Overall Status
Completed
CT.gov ID
NCT05462665
Collaborator
(none)
75
Enrollment
1
Location
2
Arms
22
Actual Duration (Months)
3.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Intravenous (IV) tissue plasminogen activator (tPA) is one of the key elements of acute ischemic stroke. In this study, acute stroke patients maximum benefit from the treatment, intravenous tissue plasminogen activator (IV tPA) minimizing the errors related to the treatment of acute ischemic stroke patients of nursing students from clinical practice guides published on the treatment of It is aimed to be informed and to standardize nursing interventions.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: theory training
  • Behavioral: theory and simulation training
 N/A

Detailed Description

Time management in acute stroke patients is possible with a multidisciplinary approach and team members who have received specific training for acute stroke patients. Studies have shown that the maximum result of treatment for acute stroke patients depends on nurses' ability to identify disease symptoms, plan and apply symptom-specific nursing care. There is evidence that the multidisciplinary presence of stroke teams in stroke units and the delivery of coordinated care during the acute phase improve patient outcomes . Coordinated care by the stroke team improves patient outcomes, reduces hospital costs, reduces patient readmission, and improves patient care quality.

Study Design

Study Type:
Interventional
Actual Enrollment :
75 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Intern nurses will be numbered from 1 to 75 and will be randomly divided into study and control groups from the random numbers table. After the groups are determined by the randomization method, each intern nurse in the study and control groups will be interviewed face to face and their written informed consent will be obtained. Then, all nursing intern students participating in the research will be asked to fill in the IV tPA Treatment Knowledge Level Evaluation Form, Self-Efficacy Competence Scale. Intern nurses in both groups will be given 1-hour theoretical training on IV tPA treatment before, during and after the procedure. In addition, simulation-based training will be applied to the intern nurses in the study group regarding IV tPA treatment before, during and after the procedure.Intern nurses will be numbered from 1 to 75 and will be randomly divided into study and control groups from the random numbers table. After the groups are determined by the randomization method, each intern nurse in the study and control groups will be interviewed face to face and their written informed consent will be obtained. Then, all nursing intern students participating in the research will be asked to fill in the IV tPA Treatment Knowledge Level Evaluation Form, Self-Efficacy Competence Scale. Intern nurses in both groups will be given 1-hour theoretical training on IV tPA treatment before, during and after the procedure. In addition, simulation-based training will be applied to the intern nurses in the study group regarding IV tPA treatment before, during and after the procedure.
Masking:
Single (Participant)
Masking Description:
Intern nurses will be numbered from 1 to 75 and will be randomly divided into study and control groups from the random numbers table. After the groups are determined by the randomization method, each intern nurse in the study and control groups will be interviewed face to face and their written informed consent will be obtained. Then, all nursing intern students participating in the research will be asked to fill in the IV tPA Treatment Knowledge Level Evaluation Form, Self-Efficacy Competence Scale. Intern nurses in both groups will be given 1-hour theoretical training on IV tPA treatment before, during and after the procedure. In addition, simulation-based training will be applied to the intern nurses in the study group regarding IV tPA treatment before, during and after the procedure.
Primary Purpose:
Treatment
Official Title:
Evaluation of the Intravenous Tissue Plasminogen Activator Treatment Algorithm of Nursing Intern Students and Evaluation of the Efficiency of Simulation Method in the Development of Self-Efficacy Proficiency Levels
Actual Study Start Date :
May 1, 2020
Actual Primary Completion Date :
Mar 1, 2022
Actual Study Completion Date :
Mar 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: intervention

Nursing intern students (n:39) will be given theory training about tPA treatment

Behavioral: theory training
theory training
Other Names:
  • tPA treatment knowledge of nursing students will increase

    		•
    Experimental: Control

    Nursing intern students (n:39) will be given theory training and simulation training about tPA treatment

    Behavioral: theory training
    theory training
    Other Names:
  • tPA treatment knowledge of nursing students will increase

    • Behavioral: theory and simulation training
    theory and simulation training
    Other Names:
  • tPA treatment knowledge of nursing students will increase

    		•

    Outcome Measures

    Primary Outcome Measures

    1. self-efficacy scale [Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention]

      Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after theoric teaching

    2. simulation scale [2 weeks after simulation training]

      evaluation the simulation design

    3. tPA treatment information form [Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention]

      Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after simulation and theoric teaching

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 30 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Intern nursing student at Dokuz Eylül University

    Exclusion Criteria:

    Those who did not agree to participate in the study Those who were not be intern

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ozge Soydaner İzmir Turkey

    Sponsors and Collaborators

    • Dokuz Eylul University

    Investigators

    • Study Director: GULSAH GUROL ARSLAN, DOKUZ EU

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    OZGE SOYDANER, nurse, Dokuz Eylul University
    ClinicalTrials.gov Identifier:
    NCT05462665
    Other Study ID Numbers:
    • tPA Treatment
    First Posted:
    Jul 18, 2022
    Last Update Posted:
    Jul 18, 2022
    Last Verified:
    Dec 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by OZGE SOYDANER, nurse, Dokuz Eylul University
    tissue plasminogen activator
    acute stroke
    intravenous tissue plasminogen activator
    nursing care
    neurology nursing
    acute stroke treatment
    Additional relevant MeSH terms:
    Stroke

    Study Results

    No Results Posted as of Jul 18, 2022